Personalized Stem Cells - FDA Approved Clinical Trials
  • Home
  • Patient
    • FAQ
  • Physician
  • Clinical Trials
    • Knee Osteoarthritis (fully enrolled)
    • COVID-19 Clinical Trials
    • Future Clinical Trials
  • About
    • Personalized Stem Cells
    • Leadership
    • Investors
  • Media
    • News
    • Blog
    • Videos
    • Facebook
  • Contact
  • 833-772-3557
Select Page
How a Stem Cell COVID-19 Clinical Trial Benefited Elephants

How a Stem Cell COVID-19 Clinical Trial Benefited Elephants

by Ashley | Mar 18, 2022 | Blog, COVID-19, Stem Cell

Yes, you read that title right. Stem cell therapy for COVID-19 is helping elephants! As you may know, Personalized Stem Cells developed and received FDA approval for a COVID-19 stem cell clinical trial in 2020. We later went on to license that trial to an outside...
Brazilian Clearance of New COVID Study Licensed to Sorrento Therapeutics

Brazilian Clearance of New COVID Study Licensed to Sorrento Therapeutics

by Ashley | Feb 18, 2022 | Blog, COVID-19

For those who keep up with Personalized Stem Cells in the news, you already know that we developed and secured FDA approval for a COVID-19 stem cell clinical trial in 2020. We went on to license this trial to Sorrento Therapeutics. The first trial was conducted at...
Brazilian Phase 2 COVID-19 Stem Cell Clinical Trial Update

Brazilian Phase 2 COVID-19 Stem Cell Clinical Trial Update

by Ashley | Oct 1, 2021 | Blog, Clinical Trial, COVID-19, Stem Cell Therapy

For those who follow our blog, you are probably aware that Personalized Stem Cells (PSC) developed and received FDA approval for a COVID-19 stem cell clinical trial in 2020. We then went on to out-license this clinical trial, along with our allogeneic stem cell...
Brazilian Approval for COVID-19 Phase 2 Clinical Trial

Brazilian Approval for COVID-19 Phase 2 Clinical Trial

by Ashley | Jun 11, 2021 | Blog, Clinical Trial, COVID-19

Lately, it seems, we are sharing updates regarding the COVID-19 cell therapy product and clinical trial every other week. The developments seem to be coming at a breakneck speed, as is warranted when faced with a crisis like the COVID-19 pandemic. Our latest news...

Personalized Stem Cells Announces Brazilian Approval for COVID-19 Clinical Trial Licensed to Sorrento Therapeutics

by Ashley | Jun 1, 2021 | Clinical Trial, COVID-19, Press Release, Stem Cell

Personalized Stem Cells, Inc (PSC), an adipose-derived stem cell company, announces the Brazilian Health Regulatory Agency (Anvisa) authorized a Phase 2 COVID-19 stem cell clinical trial. This approval comes shortly after the completion of a Phase 1b trial conducted...
Brazilian Phase 2 COVID-19 Stem Cell Clinical Trial Update

Enrollment Complete for COVID-19 Stem Cell Clinical Trial

by Ashley | May 14, 2021 | Blog, COVID-19, Stem Cell

In our most recent blog, we shared an update regarding the COVID-19 stem cell clinical trial that Personalized Stem Cells developed and secured FDA approval for. The trial, which we licensed to Sorrento Therapeutics, is studying the effects of allogeneic (donor...
« Older Entries
Copyright © 2023. Personalized Stem Cells. All rights reserved. Privacy Policy
/* First CSS File */ var giftofspeed = document.createElement('link'); giftofspeed.rel = 'stylesheet'; giftofspeed.href = 'https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css'; giftofspeed.type = 'text/css'; var godefer = document.getElementsByTagName('link')[0]; godefer.parentNode.insertBefore(giftofspeed, godefer);